Global Prostate Cancer Market Growth, Trends & Forecasts 2017 - 2022

  • ID: 4387070
  • Report
  • Region: Global
  • 205 pages
  • Mordor Intelligence
1 of 4
The Global Prostate Cancer Market is expected to reach $72 billion by the end of 2020 growing at a CAGR of around 9.7% from 2014 to 2021. Prostate cancer is an advancement of cancer in the prostate, a gland present in the male reproductive system which exists directly under the bladder in front of the rectum. The cancer cells may spread from the prostate to the other parts of the body, viz. the bones and lymph nodes. In the later stages of cancer it can cause difficulty in urination, blood in the urine, etc. Old age, family history and race are some of the factors that increase the risk of prostate cancer. Prostate cancer is most of the times diagnosed by biopsy.

U.S is considered to be the largest market of prostate cancer because the incidence of prostate cancer is common in African American population. The Global Prostate Cancer Market is segmented on the basis of Diagnostic Techniques (Digital Rectal Exam (DRE) and Prostate Specific Antigen Test (PSA)), Surgery (Radical Prostatectomy, Orchidectomy and Trans Urethral Resection (TUR)), Radiation Therapy (External Beam Radiation Therapy which includes 3D Conformal Radiation Therapy, Intensity Modulated Radiation Therapy, Stereotactic Body Radiation Therapy and Proton Beam Radiation Therapy, and Brachytherapy which includes Permanent Brachytherapy and Temporary Brachytherapy), Chemotherapy (Docetaxel, Etoposide, Vinblastine, Carboplatin and Vinorelbine) and Region (North America, Europe, Asia Pacific and Rest of the World).

Drivers

Change in lifestyle, technological advancements in finding new techniques to fight prostate cancer, rise in the funding in both public and private sector in the field of drug development are some of the reasons driving the growth of the market.

Challenges

High cost of treatment, side effects of surgery like urinary incontinence & impotence and surgical risks like heart attack, stroke, blood clots etc. are some of the constraints faced by the market.

This Report Offers:

Market Definition for the specified topic along with identification of key drivers and restraints for the market.

Market analysis for the Global Prostate Cancer Market, with region specific assessments and competition analysis on a global and regional scale.

Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.

Identification and analysis of the Macro and Micro factors that affect the Global Prostate Cancer Market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1. Introduction
1.1 Report Description
1.2 Markets Covered
1.3 Research Methodology
2. Executive Summary
3. Market Overview
3.1 Market Definition
3.2 Market Drivers
3.2.1 Change in lifestyle
3.2.2 Technological advancements in finding new techniques to fight prostate cancer
3.2.3 Rise in the funding in both public and private sector in the field of drug development
3.3 Market Restraints
3.3.1 High cost of treatment
3.3.2 Side effects of surgery like urinary incontinence & impotence
3.3.3 Surgical risks like heart attack, stroke, blood clots etc.
3.4 Market Opportunitites
3.5 Market Threats
4. Porters Five Force Analysis
4.1 Bargaining Power of suppliers
4.2 Bargaining power of buyers
4.3 Degree of competition
4.4 Threat of substitution
4.5 Threat of new entrants
5. Market Segmentation
5.1 Global Prostate Cancer Market
5.1.1 By Diagnostic Techniques
5.1.1.1 Digital Rectal Exam (DRE)
5.1.1.2 Prostate Specific Antigen Test (PSA)
5.1.2 By Surgery
5.1.2.1 Radical Prostatectomy
5.1.2.2 Orchidectomy
5.1.2.3 Trans Urethral Resection (TUR)
5.1.3 By Radiation Therapy
5.1.3.1 External Beam Radiation Therapy
5.1.3.1.1 3D Conformal Radiation Therapy
5.1.3.1.2 Intensity Modulated Radiation Therapy
5.1.3.1.3 Stereotactic Body Radiation Therapy
5.1.3.1.4 Proton Beam Radiation Therapy
5.1.3.2 Brachytherapy
5.1.3.2.1 Permanent Brachytherapy
5.1.3.2.2 Temporary Brachytherapy
5.1.4 By Chemotherapy
5.1.4.1 Docetaxel
5.1.4.2 Etoposide
5.1.4.3 Vinblastine
5.1.4.4 Carboplatin
5.1.4.5 Vinorelbine
5.1.5 By Geography
5.1.5.1 North America
5.1.5.1.1 USA
5.1.5.1.2 Canada
5.1.5.1.3 Mexico
5.1.5.2 Europe
5.1.5.2.1 UK
5.1.5.2.2 Germany
5.1.5.2.3 France
5.1.5.2.4 Italy
5.1.5.2.5 Spain
5.1.5.3 Asia Pacific
5.1.5.3.1 China
5.1.5.3.2 Japan
5.1.5.3.3 India
5.1.5.3.4 Australia
5.1.5.4 ROW
6. Competitive Landscape
6.1 Mergers & Acquisitions
6.2 Agreements, Collaborations & Partnerships
6.3 New Product Launches
6.4 Recommendations to new market players
7. Company Profiles
7.1 GE Healthcare
7.2 Seimens Healthcare
7.3 Johnson & Johnson
7.4 Pfizer
7.5 Bayer
7.6 Ipsen
7.7 Dendreon
7.8 Sanofi
7.9 Amgen
7.10 Glaxosmithkline

List of Tables

1: Global Prostate Cancer Market($ million)(2017 - 2022).
2: Global Prostate Cancer Market-By Diagnostic Techniques-($ million)(2017 - 2022).
3: Global Prostate Cancer Market-By Diagnostic Techniques-Digital Rectal Exam (DRE)-($ million)(2017 - 2022).
4: Global Prostate Cancer Market-By Diagnostic Techniques-Prostate Specific Antigen Test (PSA)-($ million)(2017 - 2022).
5: Global Prostate Cancer Market-By Surgery-($ million)(2017 - 2022).
6: Global Prostate Cancer Market-By Surgery-Radical Prostatectomy -($ million)(2017 - 2022).
7: Global Prostate Cancer Market-By Surgery-Orchidectomy-($ million)(2017 - 2022).
8: Global Prostate Cancer Market-By Surgery-Trans Urethral Resection (TUR)-($ million)(2017 - 2022).
9: Global Prostate Cancer Market-By Radiation Therapy-($ million)(2017 - 2022).
10: Global Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-($ million)(2017 - 2022).
11: Global Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-3D Conformal Radiation Therapy-($ million)(2017 - 2022).
12: Global Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-Intensity Modulated Radiation Therapy-($ million)(2017 - 2022).
13: Global Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-Stereotactic Body Radiation Therapy-($ million)(2017 - 2022).
14: Global Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-Proton Beam Radiation Therapy-($ million)(2017 - 2022).
15: Global Prostate Cancer Market-By Radiation Therapy-Brachytherapy-($ million)(2017 - 2022).
16: Global Prostate Cancer Market-By Radiation Therapy-Brachytherapy-Permanent Brachytherapy-($ million)(2017 - 2022).
17: Global Prostate Cancer Market-By Radiation Therapy-Brachytherapy-Temporary Brachytherapy-($ million)(2017 - 2022).
18: Global Prostate Cancer Market-By Chemotherapy-($ million)(2017 - 2022).
19: Global Prostate Cancer Market-By Chemotherapy-Docetaxel-($ million)(2017 - 2022).
20: Global Prostate Cancer Market-By Chemotherapy-Etoposide-($ million)(2017 - 2022).
21: Global Prostate Cancer Market-By Chemotherapy-Vinblastine-($ million)(2017 - 2022).
22: Global Prostate Cancer Market-By Chemotherapy-Carboplatin-($ million)(2017 - 2022).
23: Global Prostate Cancer Market-By Chemotherapy-Vinorelbine-($ million)(2017 - 2022).
24: North American Prostate Cancer Market($ million)(2017 - 2022).
25: North American Prostate Cancer Market-By Diagnostic Techniques-($ million)(2017 - 2022).
26: North American Prostate Cancer Market-By Diagnostic Techniques-Digital Rectal Exam (DRE)-($ million)(2017 - 2022).
27: North American Prostate Cancer Market-By Diagnostic Techniques-Prostate Specific Antigen Test (PSA)-($ million)(2017 - 2022).
28: North American Prostate Cancer Market-By Surgery-($ million)(2017 - 2022).
29: North American Prostate Cancer Market-By Surgery-Radical Prostatectomy -($ million)(2017 - 2022).
30: North American Prostate Cancer Market-By Surgery-Orchidectomy-($ million)(2017 - 2022).
31: North American Prostate Cancer Market-By Surgery-Trans Urethral Resection (TUR)-($ million)(2017 - 2022).
32: North American Prostate Cancer Market-By Radiation Therapy-($ million)(2017 - 2022).
33: North American Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-($ million)(2017 - 2022).
34: North American Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-3D Conformal Radiation Therapy-($ million)(2017 - 2022).
35: North American Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-Intensity Modulated Radiation Therapy-($ million)(2017 - 2022).
36: North American Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-Stereotactic Body Radiation Therapy-($ million)(2017 - 2022).
37: North American Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-Proton Beam Radiation Therapy-($ million)(2017 - 2022).
38: North American Prostate Cancer Market-By Radiation Therapy-Brachytherapy-($ million)(2017 - 2022).
39: North American Prostate Cancer Market-By Radiation Therapy-Brachytherapy-Permanent Brachytherapy-($ million)(2017 - 2022).
40: North American Prostate Cancer Market-By Radiation Therapy-Brachytherapy-Temporary Brachytherapy-($ million)(2017 - 2022).
41: North American Prostate Cancer Market-By Chemotherapy-($ million)(2017 - 2022).
42: North American Prostate Cancer Market-By Chemotherapy-Docetaxel-($ million)(2017 - 2022).
43: North American Prostate Cancer Market-By Chemotherapy-Etoposide-($ million)(2017 - 2022).
44: North American Prostate Cancer Market-By Chemotherapy-Vinblastine-($ million)(2017 - 2022).
45: North American Prostate Cancer Market-By Chemotherapy-Carboplatin-($ million)(2017 - 2022).
46: North American Prostate Cancer Market-By Chemotherapy-Vinorelbine-($ million)(2017 - 2022).
47: European Prostate Cancer Market($ million)(2017 - 2022).
48: European Prostate Cancer Market-By Diagnostic Techniques-($ million)(2017 - 2022).
49: European Prostate Cancer Market-By Diagnostic Techniques-Digital Rectal Exam (DRE)-($ million)(2017 - 2022).
50: European Prostate Cancer Market-By Diagnostic Techniques-Prostate Specific Antigen Test (PSA)-($ million)(2017 - 2022).
51: European Prostate Cancer Market-By Surgery-($ million)(2017 - 2022).
52: European Prostate Cancer Market-By Surgery-Radical Prostatectomy -($ million)(2017 - 2022).
53: European Prostate Cancer Market-By Surgery-Orchidectomy-($ million)(2017 - 2022).
54: European Prostate Cancer Market-By Surgery-Trans Urethral Resection (TUR)-($ million)(2017 - 2022).
55: European Prostate Cancer Market-By Radiation Therapy-($ million)(2017 - 2022).
56: European Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-($ million)(2017 - 2022).
57: European Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-3D Conformal Radiation Therapy-($ million)(2017 - 2022).
58: European Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-Intensity Modulated Radiation Therapy-($ million)(2017 - 2022).
59: European Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-Stereotactic Body Radiation Therapy-($ million)(2017 - 2022).
60: European Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-Proton Beam Radiation Therapy-($ million)(2017 - 2022).
61: European Prostate Cancer Market-By Radiation Therapy-Brachytherapy-($ million)(2017 - 2022).
62: European Prostate Cancer Market-By Radiation Therapy-Brachytherapy-Permanent Brachytherapy-($ million)(2017 - 2022).
63: European Prostate Cancer Market-By Radiation Therapy-Brachytherapy-Temporary Brachytherapy-($ million)(2017 - 2022).
64: European Prostate Cancer Market-By Chemotherapy-($ million)(2017 - 2022).
65: European Prostate Cancer Market-By Chemotherapy-Docetaxel-($ million)(2017 - 2022).
66: European Prostate Cancer Market-By Chemotherapy-Etoposide-($ million)(2017 - 2022).
67: European Prostate Cancer Market-By Chemotherapy-Vinblastine-($ million)(2017 - 2022).
68: European Prostate Cancer Market-By Chemotherapy-Carboplatin-($ million)(2017 - 2022).
69: European Prostate Cancer Market-By Chemotherapy-Vinorelbine-($ million)(2017 - 2022).
70: Asia Pacific Prostate Cancer Market($ million)(2017 - 2022).
71: Asia Pacific Prostate Cancer Market-By Diagnostic Techniques-($ million)(2017 - 2022).
72: Asia Pacific Prostate Cancer Market-By Diagnostic Techniques-Digital Rectal Exam (DRE)-($ million)(2017 - 2022).
73: Asia Pacific Prostate Cancer Market-By Diagnostic Techniques-Prostate Specific Antigen Test (PSA)-($ million)(2017 - 2022).
74: Asia Pacific Prostate Cancer Market-By Surgery-($ million)(2017 - 2022).
75: Asia Pacific Prostate Cancer Market-By Surgery-Radical Prostatectomy -($ million)(2017 - 2022).
76: Asia Pacific Prostate Cancer Market-By Surgery-Orchidectomy-($ million)(2017 - 2022).
77: Asia Pacific Prostate Cancer Market-By Surgery-Trans Urethral Resection (TUR)-($ million)(2017 - 2022).
78: Asia Pacific Prostate Cancer Market-By Radiation Therapy-($ million)(2017 - 2022).
79: Asia Pacific Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-($ million)(2017 - 2022).
80: Asia Pacific Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-3D Conformal Radiation Therapy-($ million)(2017 - 2022).
81: Asia Pacific Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-Intensity Modulated Radiation Therapy-($ million)(2017 - 2022).
82: Asia Pacific Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-Stereotactic Body Radiation Therapy-($ million)(2017 - 2022).
83: Asia Pacific Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-Proton Beam Radiation Therapy-($ million)(2017 - 2022).
84: Asia Pacific Prostate Cancer Market-By Radiation Therapy-Brachytherapy-($ million)(2017 - 2022).
85: Asia Pacific Prostate Cancer Market-By Radiation Therapy-Brachytherapy-Permanent Brachytherapy-($ million)(2017 - 2022).
86: Asia Pacific Prostate Cancer Market-By Radiation Therapy-Brachytherapy-Temporary Brachytherapy-($ million)(2017 - 2022).
87: Asia Pacific Prostate Cancer Market-By Chemotherapy-($ million)(2017 - 2022).
88: Asia Pacific Prostate Cancer Market-By Chemotherapy-Docetaxel-($ million)(2017 - 2022).
89: Asia Pacific Prostate Cancer Market-By Chemotherapy-Etoposide-($ million)(2017 - 2022).
90: Asia Pacific Prostate Cancer Market-By Chemotherapy-Vinblastine-($ million)(2017 - 2022).
91: Asia Pacific Prostate Cancer Market-By Chemotherapy-Carboplatin-($ million)(2017 - 2022).
92: Asia Pacific Prostate Cancer Market-By Chemotherapy-Vinorelbine-($ million)(2017 - 2022).
93: Rest of the World Prostate Cancer Market($ million)(2017 - 2022).
94: Rest of the World Prostate Cancer Market-By Diagnostic Techniques-($ million)(2017 - 2022).
95: Rest of the World Prostate Cancer Market-By Diagnostic Techniques-Digital Rectal Exam (DRE)-($ million)(2017 - 2022).
96: Rest of the World Prostate Cancer Market-By Diagnostic Techniques-Prostate Specific Antigen Test (PSA)-($ million)(2017 - 2022).
97: Rest of the World Prostate Cancer Market-By Surgery-($ million)(2017 - 2022).
98: Rest of the World Prostate Cancer Market-By Surgery-Radical Prostatectomy -($ million)(2017 - 2022).
99: Rest of the World Prostate Cancer Market-By Surgery-Orchidectomy-($ million)(2017 - 2022).
100: Rest of the World Prostate Cancer Market-By Surgery-Trans Urethral Resection (TUR)-($ million)(2017 - 2022).
101: Rest of the World Prostate Cancer Market-By Radiation Therapy-($ million)(2017 - 2022).
102: Rest of the World Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-($ million)(2017 - 2022).
103: Rest of the World Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-3D Conformal Radiation Therapy-($ million)(2017 - 2022).
104: Rest of the World Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-Intensity Modulated Radiation Therapy-($ million)(2017 - 2022).
105: Rest of the World Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-Stereotactic Body Radiation Therapy-($ million)(2017 - 2022).
106: Rest of the World Prostate Cancer Market-By Radiation Therapy-External Beam Radiation Therapy-Proton Beam Radiation Therapy-($ million)(2017 - 2022).
107: Rest of the World Prostate Cancer Market-By Radiation Therapy-Brachytherapy-($ million)(2017 - 2022).
108: Rest of the World Prostate Cancer Market-By Radiation Therapy-Brachytherapy-Permanent Brachytherapy-($ million)(2017 - 2022).
109: Rest of the World Prostate Cancer Market-By Radiation Therapy-Brachytherapy-Temporary Brachytherapy-($ million)(2017 - 2022).
110: Rest of the World Prostate Cancer Market-By Chemotherapy-($ million)(2017 - 2022).
111: Rest of the World Prostate Cancer Market-By Chemotherapy-Docetaxel-($ million)(2017 - 2022).
112: Rest of the World Prostate Cancer Market-By Chemotherapy-Etoposide-($ million)(2017 - 2022).
113: Rest of the World Prostate Cancer Market-By Chemotherapy-Vinblastine-($ million)(2017 - 2022).
114: Rest of the World Prostate Cancer Market-By Chemotherapy-Carboplatin-($ million)(2017 - 2022).
115: Rest of the World Prostate Cancer Market-By Chemotherapy-Vinorelbine-($ million)(2017 - 2022).
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll